Doctors are a diverse group of people. From GPs to specialists, with the more than 60 areas of medicine that …
The NHS tsar for primary care has called on clinicians to challenge the way they undertake clinical practice in order …
Plans to redesign the primary care landscape with the creation of purpose-built super surgeries are in many cases unfeasible, according …
GlaxoSmithKline has awarded the pan-European launch of a major new neurological product to Euro RSCG Life MSC, following a three-way …
Website links to details of more than 4,000 clinical trials have been published by the ABPI, as the global agreement …
Pfizer has pulled out of an agreement with Altana Pharma to develop and market a new treatment for asthma and …
Pharma economists will tell you that the world has a market 'top three'. The US is way ahead in the …
UK-based pharmaceutical companies have pre-empted strict new European rules on entertaining healthcare professionals by imposing their own restrictions.The companies are …
Eli Lilly has signed a licensing agreement with Japanese pharmaceutical company Taisho for TS-021, a novel treatment for type II …
The FDA is conducting another review of antidepressants to determine whether the drugs increase the risk of suicidal behaviour in …
GlaxoSmithKline has updated investors on its vaccine pipeline, with the company expecting to launch five major vaccines within as many …
Doctors have expressed concern that they do not have time to act as mentors to independent nurse prescribers, according to …
In light of the enormous potential brand benefits of pharma PR, the question should not be 'Shall we invest in …
Abbott's Humira has moved closer to European approval as a first-line treatment of moderate to severe early rheumatoid arthritis in …